Moomoo AI 已提取核心訊息
Allarity Therapeutics, Inc. has announced a virtual Special Meeting of Stockholders to be held on a to-be-determined date in March 2024. The meeting will address two key proposals: a Reverse Stock Split Proposal and an Adjournment Proposal. The Reverse Stock Split Proposal, if approved, would allow the Board of Directors to effect a reverse stock split of the company's issued and outstanding common stock at a ratio between 1-for-5 and 1-for-20, at the Board's discretion. The Adjournment Proposal seeks approval to adjourn the meeting, if necessary, to solicit additional proxies in favor of the Reverse Stock Split Proposal. Stockholders as of February 21, 2024, are entitled to vote, with holders of Common Stock and Series A Convertible Preferred Stock...Show More
Allarity Therapeutics, Inc. has announced a virtual Special Meeting of Stockholders to be held on a to-be-determined date in March 2024. The meeting will address two key proposals: a Reverse Stock Split Proposal and an Adjournment Proposal. The Reverse Stock Split Proposal, if approved, would allow the Board of Directors to effect a reverse stock split of the company's issued and outstanding common stock at a ratio between 1-for-5 and 1-for-20, at the Board's discretion. The Adjournment Proposal seeks approval to adjourn the meeting, if necessary, to solicit additional proxies in favor of the Reverse Stock Split Proposal. Stockholders as of February 21, 2024, are entitled to vote, with holders of Common Stock and Series A Convertible Preferred Stock voting together on the proposals. The meeting is part of Allarity's efforts to comply with NASDAQ's minimum bid price requirements and to potentially increase marketability and liquidity of the company's stock. The Board and management emphasize the importance of stockholder votes at the Special Meeting, which will be conducted exclusively online via live audio webcast.
Alarity Therapeutics, Inc.已宣佈將在2024年3月舉行虛擬股東特別會議，日期待定。會議將討論兩個關鍵提案：反向股票拆分提案和休會提案。反向股票拆分提案如果獲得批准，將允許董事會自行決定以1比5和1比20的比例對公司的已發行和流通普通股進行反向股票分割。休會提案尋求批准，必要時休會，以徵集更多支持反向股票拆分提案的代理人。截至2024年2月21日，股東有權投票，普通股和A系列可轉換優先股的持有人共同對提案進行投票。這次會議是Allarity努力遵守納斯達克最低出價要求並有可能提高公司股票的適銷性和流動性的努力的一部分。董事會和管理層在特別會議上強調股東投票的重要性，特別會議將通過網絡直播完全在線進行。
Alarity Therapeutics, Inc.已宣佈將在2024年3月舉行虛擬股東特別會議，日期待定。會議將討論兩個關鍵提案：反向股票拆分提案和休會提案。反向股票拆分提案如果獲得批准，將允許董事會自行決定以1比5和1比20的比例對公司的已發行和流通普通股進行反向股票分割。休會提案尋求批准，必要時休會，以徵集更多支持反向股票拆分提案的代理人。截至2024年2月21日，股東有權投票，普通股和A系列可轉換優先股的持有人共同對提案進行投票。這次會議是Allarity努力遵守納斯達克最低出價要求並有可能提高公司股票的適銷性和流動性的努力的一部分。董事會和管理層在特別會議上強調股東投票的重要性，特別會議將通過網絡直播完全在線進行。
有用
沒用
